1zmy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 5: Line 5:
|SITE=
|SITE=
|LIGAND=
|LIGAND=
-
|ACTIVITY= [http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17]
+
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span>
|GENE=
|GENE=
 +
|DOMAIN=
 +
|RELATEDENTRY=[[1jto|1JTO]], [[1jtp|1JTP]], [[1jtt|1JTT]], [[1mel|1MEL]]
 +
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1zmy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1zmy OCA], [http://www.ebi.ac.uk/pdbsum/1zmy PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1zmy RCSB]</span>
}}
}}
Line 33: Line 36:
[[Category: Saerens, D.]]
[[Category: Saerens, D.]]
[[Category: Wyns, L.]]
[[Category: Wyns, L.]]
-
[[Category: vhh; antibody; immune system; cdr grafting]]
+
[[Category: antibody]]
 +
[[Category: cdr grafting]]
 +
[[Category: immune system]]
 +
[[Category: vhh]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 15:37:30 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 01:38:56 2008''

Revision as of 22:39, 30 March 2008


PDB ID 1zmy

Drag the structure with the mouse to rotate
, resolution 3.00Å
Activity: Lysozyme, with EC number 3.2.1.17
Related: 1JTO, 1JTP, 1JTT, 1MEL


Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



cAbBCII-10 VHH framework with CDR loops of cAbLys3 grafted on it and in complex with hen egg white lysozyme


Overview

Camel single-domain antibody fragments (VHHs) are promising tools in numerous biotechnological and medical applications. However, some conditions under which antibodies are used are so demanding that they can be met by only the most robust VHHs. A universal framework offering the required properties for use in various applications (e.g. as intrabody, as probe in biosensors or on micro-arrays) is highly valuable and might be further implemented when employment of VHHs in human therapy is envisaged. We identified the VHH framework of cAbBCII10 as a potential candidate, useful for the exchange of antigen specificities by complementarity determining region (CDR) grafting. Due to the large number of CDR-H loop structures present on VHHs, this grafting technique was expected to be rather unpredictable. Nonetheless, the plasticity of the cAbBCII10 framework allows successful transfer of antigen specificity from donor VHHs onto its scaffold. The cAbBCII10 was chosen essentially for its high level of stability (47 kJmol(-1)), good expression level (5 mgl(-1) in E.coli) and its ability to be functional in the absence of the conserved disulfide bond. All five chimeras generated by grafting CDR-Hs, from donor VHHs belonging to subfamily 2 that encompass 75% of all antigen-specific VHHs, on the framework of cAbBCII10 were functional and generally had an increased thermodynamic stability. The grafting of CDR-H loops from VHHs belonging to other subfamilies resulted in chimeras of reduced antigen-binding capacity.

About this Structure

1ZMY is a Single protein structure of sequence from Camelus dromedarius and Gallus gallus. Full crystallographic information is available from OCA.

Reference

Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies., Saerens D, Pellis M, Loris R, Pardon E, Dumoulin M, Matagne A, Wyns L, Muyldermans S, Conrath K, J Mol Biol. 2005 Sep 23;352(3):597-607. PMID:16095608

Page seeded by OCA on Mon Mar 31 01:38:56 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools